ADAMTS13 and androgen insensitivity syndrome: In addition, animal studies on ADAMTS13 in the treatment of AIS are delivering promising results, especially in the model of conformational activation; as such, ADAMTS13 may become a new therapeutic agent for ischemic stroke [76].